eduardo huarte
PTC Therapeutics (United States)
South Plainfield, United States
Review Editor
Cancer Immunity and Immunotherapy
Editors
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
amy hughes
South Australian Health and Medical Research Institute (SAHMRI)
Adelaide, Australia
Review Editor
Cancer Immunity and Immunotherapy
etienne humblin
Icahn School of Medicine at Mount Sinai
New York, United States
Review Editor
Cancer Immunity and Immunotherapy
lenka v. hurton
Castle Biosciences, Inc.
Friendswood, United States
Review Editor
Cancer Immunity and Immunotherapy
michael e hurwitz
Yale University
New Haven, United States
Review Editor
Cancer Immunity and Immunotherapy
tae-ho hwang
Pusan National University
Busan, Republic of Korea
Review Editor
Cancer Immunity and Immunotherapy
bastian höchst
Technical University of Munich
Munich, Germany
Review Editor
Cancer Immunity and Immunotherapy
sami ibrahimi
Stephenson Cancer Center, College of Medicine, University of Oklahoma
Oklahoma, United States
Review Editor
Cancer Immunity and Immunotherapy
kamran idrees
Vanderbilt Ingram Cancer Center
Nashville, United States
Review Editor
Cancer Immunity and Immunotherapy
giandomenica iezzi
University of Italian Switzerland
Lugano, Switzerland
Review Editor
Cancer Immunity and Immunotherapy
sejin im
Sungkyunkwan University
Jongno-gu, Republic of Korea
Review Editor
Cancer Immunity and Immunotherapy
khan m imran
School of Medicine, University of North Carolina at Chapel Hill
Chapel Hill, United States
Review Editor
Cancer Immunity and Immunotherapy
marit inngjerdingen
Department of Pharmacology, Institute of Clinical Medicine, University of Oslo
Oslo, Norway
Review Editor
Cancer Immunity and Immunotherapy
susana inogés
Cell Therapy Area, University Clinic of Navarra
Pamplona, Spain
Review Editor
Cancer Immunity and Immunotherapy
madiha iqbal
Mayo Clinic
Rochester, United States
Review Editor
Cancer Immunity and Immunotherapy
mark elia issa
Karolinska Institutet (KI)
Solna, Sweden
Review Editor
Cancer Immunity and Immunotherapy